| [1] |
Fux Otta C，Fiol de Cuneo M，Szafryk de Mereshian P．Polycystic ovary syndrome: physiopathology review[J]．Rev Fac Cien Med Univ Nac Cordoba，2013，70(1)：27–30.
|
| [2] |
Cornier MA，Dabelea D，Hernandez TL，et al. The metabolic syndrome[J]．Endocr Rev，2008，29(7)：777–822.
|
| [3] |
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]．Hum Reprod，2004，19(1)：41–47.
|
| [4] |
DeUgarte CM，Bartolucci AA，Azziz R．Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment[J]．Fertil Steril，2005，83(5)：1454–1460.
|
| [5] |
Yildiz BO，Knochenhauer ES，Azziz R．Impact of obesity on the risk for polycystic ovary syndrome[J]．J Clin Endocrinol Metab，2008，93(1)：162–168.
|
| [6] |
Alberti KG，Zimmet P，Shaw J．Metabolic syndrome-a new world-wide definition.a Consensus Statement from the International Diabetes Federation[J]．Diabet Med，2006，23(5)：469–480.
|
| [7] |
Caserta D，Adducchio G，Picchia S，et al. Metabolic syndrome and polycystic ovary syndrome：an intriguing overlapping[J]．Gynecol Endocrinol，2014，30(6): 397–402.
|
| [8] |
Kandaraki E，Christakou C，Diamanti-Kandarakis E．Metabolic syndrome and polycystic ovary syndrome...and vice versa[J]．Arq Bras Endocrinol Metabol，2009，53(2)：227–237.
|
| [9] |
Diamanti-Kandarakis E，Papavassiliou AG，Kandarakis SA，et al.Pathophysiology and types of dyslipidemia in PCOS[J]．Trends Endocrinol Metab，2007，18(7)：280–285.
|
| [10] |
Diamanti-Kandarakis E，Palioniko G，Alexandraki K，et al.The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1(PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels[J]．Eur J Endocrinol，2004，150(6)：793–798.
|
| [11] |
González F，Rote NS，Minium J，et al.Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome[J]．J Clin Endocrinol Metab，2006，91(1)：336–340.
|
| [12] |
Diamanti-Kandarakis E，Katsikis I，Piperi C，et al.Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome(PCOS)[J]．Clin Endocrinol(Oxf)，2008，69(4)：634–641.
|
| [13] |
Diamanti-Kandarakis E，Paterakis T，Kandarakis HA.Indices of low-grade inflammation in polycystic ovary syndrome[J]．Ann N Y Acad Sci，2006, 1092：175–186.
|
| [14] |
Gambineri A，Pelusi C，Vicennati V，et al.Obesity and the polycystic ovary syndrome[J]．Int J Obes Relat Metab Disord，2002，26(7)：883–896.
|
| [15] |
Norman RJ，Davies MJ，Lord J，et al.The role of lifestyle modification in polycystic ovary syndrome[J]．Trends Endocrinol Metab，2002，13(6)：251–257.
|
| [16] |
Farrell K，Antoni MH.Insulin resistance，obesity，inflammation，and depression in polycystic ovary syndrome：biobehavioral mechanisms and interventions[J]. Fertil Steril，2010，94(5)：1565–1574.
|
| [17] |
Holloszy JO.Exercise-induced increase in muscle insulin sensitivity[J]．J Appl Physiol(1985)，2005，99(1)：338–343.
|
| [18] |
Galluzzo A，Amato MC，Giordano C．Insulin resistance and polycystic ovary syndrome [J]．Nutr Metab Cardiovasc Dis，2008，18(7)：511–518.
|
| [19] |
Sabatini ME，Guo L，Lynch MP，et al.Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation[J]．J Ovarian Res，2011，4(1)：8.
|
| [20] |
Ndefo UA，Eaton A，Green MR.Polycystic ovary syndrome：a review of treatment options with a focus on pharmacological approaches[J]．P T，2013，38(6)：336–355.
|
| [21] |
Durbin RJ.Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance[J]．Diabetes Obes Metab，2004，6(4)：280–285.
|
| [22] |
Clinical Guidelines on the Identification，Evaluation，and Treatment of Overweight and Obesity in Adults-the Evidence Report.National Institutes of Health[J]．Obes Res，1998，6(Suppl 2)：51S–209S.
|
| [23] |
张婷婷，王琳．多囊卵巢综合征治疗进展[J]．实用中医药杂志，2012，28(3)：249–250.
|
| [24] |
Seow KM，Juan CC，Hwang JL，et al.Laparoscopic surgery in polycystic ovary syndrome：reproductive and metabolic effects[J]．Semin Reprod Med，2008，26(1): 101–110.
|